Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mobility Limitation | 7 | 2019 | 187 | 0.900 |
Why?
|
| Algorithms | 4 | 2018 | 462 | 0.820 |
Why?
|
| Disability Evaluation | 3 | 2019 | 211 | 0.720 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 103 | 0.680 |
Why?
|
| Geriatric Assessment | 5 | 2019 | 355 | 0.680 |
Why?
|
| Psychometrics | 4 | 2019 | 129 | 0.660 |
Why?
|
| Cognition | 1 | 2018 | 526 | 0.500 |
Why?
|
| Video Recording | 2 | 2013 | 52 | 0.470 |
Why?
|
| Epistasis, Genetic | 3 | 2012 | 44 | 0.440 |
Why?
|
| Prostatic Neoplasms | 3 | 2012 | 441 | 0.440 |
Why?
|
| Models, Theoretical | 2 | 2014 | 126 | 0.420 |
Why?
|
| Exercise | 4 | 2017 | 591 | 0.420 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 836 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 326 | 0.380 |
Why?
|
| Health Status | 1 | 2013 | 368 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2019 | 1379 | 0.370 |
Why?
|
| Quality of Life | 2 | 2016 | 816 | 0.330 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 1013 | 0.330 |
Why?
|
| Computational Biology | 1 | 2008 | 86 | 0.310 |
Why?
|
| Aging | 3 | 2019 | 881 | 0.280 |
Why?
|
| Aged | 13 | 2019 | 9487 | 0.250 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 176 | 0.250 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 3717 | 0.240 |
Why?
|
| Humans | 21 | 2019 | 29093 | 0.230 |
Why?
|
| Computer Simulation | 2 | 2018 | 207 | 0.220 |
Why?
|
| Male | 18 | 2019 | 17807 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 1079 | 0.210 |
Why?
|
| Walking | 2 | 2013 | 177 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 366 | 0.190 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 726 | 0.180 |
Why?
|
| Female | 15 | 2019 | 18164 | 0.180 |
Why?
|
| Risk Factors | 7 | 2017 | 3531 | 0.170 |
Why?
|
| Health Education | 2 | 2016 | 121 | 0.170 |
Why?
|
| Physical Fitness | 1 | 2019 | 119 | 0.170 |
Why?
|
| European Continental Ancestry Group | 2 | 2013 | 1131 | 0.160 |
Why?
|
| Actigraphy | 1 | 2017 | 11 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 113 | 0.150 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 116 | 0.150 |
Why?
|
| Insulin | 2 | 2015 | 346 | 0.150 |
Why?
|
| Research Design | 1 | 2018 | 286 | 0.140 |
Why?
|
| Lower Extremity | 1 | 2016 | 93 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2017 | 229 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 787 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2014 | 106 | 0.130 |
Why?
|
| Age Factors | 4 | 2019 | 1108 | 0.120 |
Why?
|
| Health Literacy | 1 | 2013 | 26 | 0.120 |
Why?
|
| Indians, North American | 1 | 2013 | 108 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 51 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2013 | 70 | 0.110 |
Why?
|
| Quality Control | 1 | 2012 | 38 | 0.110 |
Why?
|
| Life Style | 1 | 2014 | 364 | 0.110 |
Why?
|
| Motor Activity | 1 | 2014 | 310 | 0.100 |
Why?
|
| Hip Fractures | 1 | 2010 | 30 | 0.090 |
Why?
|
| Prognosis | 3 | 2019 | 1362 | 0.080 |
Why?
|
| Multifactorial Inheritance | 1 | 2008 | 19 | 0.080 |
Why?
|
| Logistic Models | 1 | 2010 | 727 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2019 | 165 | 0.080 |
Why?
|
| Time Factors | 3 | 2017 | 2001 | 0.080 |
Why?
|
| Middle Aged | 6 | 2019 | 10829 | 0.080 |
Why?
|
| Obesity | 1 | 2014 | 1063 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2008 | 104 | 0.070 |
Why?
|
| African Americans | 1 | 2013 | 1373 | 0.070 |
Why?
|
| Hypoglycemia | 2 | 2015 | 41 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 631 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2019 | 140 | 0.040 |
Why?
|
| Acceleration | 1 | 2019 | 60 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 426 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 18 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 263 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2018 | 76 | 0.040 |
Why?
|
| Alcoholism | 1 | 2018 | 95 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 60 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 25 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 720 | 0.030 |
Why?
|
| Resistance Training | 1 | 2016 | 70 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 251 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 159 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 224 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 273 | 0.030 |
Why?
|
| Culture | 1 | 2014 | 38 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2016 | 208 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1119 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2015 | 350 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 641 | 0.030 |
Why?
|
| Medicine | 1 | 2013 | 30 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 709 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 148 | 0.030 |
Why?
|
| Minority Groups | 1 | 2013 | 69 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 865 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2015 | 466 | 0.030 |
Why?
|
| Arthritis | 1 | 2013 | 37 | 0.030 |
Why?
|
| Reaction Time | 1 | 2013 | 121 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2016 | 804 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2013 | 153 | 0.030 |
Why?
|
| Child | 1 | 2018 | 2219 | 0.030 |
Why?
|
| Weight Loss | 1 | 2014 | 413 | 0.020 |
Why?
|
| Taiwan | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 251 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3254 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1687 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 543 | 0.020 |
Why?
|
| North Carolina | 1 | 2013 | 1423 | 0.020 |
Why?
|
| United States | 1 | 2017 | 3630 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2010 | 186 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2008 | 122 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 735 | 0.020 |
Why?
|
| Hypertension | 1 | 2013 | 906 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 859 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 8420 | 0.010 |
Why?
|